Bentham Science Logo

Contents

Current Drug Safety, Volume 11 - Number 1


Preface








Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile

, 11(1): 47 - 54

Piergiorgio Neri, Ilir Arapi, Michele Nicolai, Vittorio Pirani, Andrea Saitta, Michele M. Luchetti, Alfonso Giovannini and Cesare Mariotti


DOI: 10.2174/1574886310666151014114925





Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis

, 11(1): 78 - 85

Aaron D. Drovandi, Carla C. Chen and Beverley D. Glass


DOI: 10.2174/1574886311207040282



Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice

, 11(1): 86 - 98

Guillermo A. Keller, Paulino A. Alvarez, Marcelo L. Ponte, Waldo H. Belloso, Claudia Bagnes, Cecilia Sparanochia, Claudio D. Gonzalez, M. Cecilia Villa Etchegoyen, Roberto A. Diez and Guillermo Di Girolamo


DOI: 10.2174/1574886311207040262




Recognizing Severe Adverse Drug Reactions: Two Case Reports After Switching Therapies to the Same Generic Company

, 11(1): 104 - 108

Luca Gallelli, Giuseppe Gallelli, Giuseppe Codamo, Angela Argentieri, Andzelika Michniewicz, Antonio Siniscalchi, Roberta Stefanelli, Erika Cione, Maria C. Caroleo, Paola Longo and Giovambattista De Sarro


DOI: 10.2174/1574886311207040309


Erratum



Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science